Palo Alto Investors’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.97M | Buy |
1,390,028
+614,000
| +79% | +$872K | 0.42% | 29 |
|
|
2025
Q1 | $1.19M | Buy |
776,028
+206,196
| +36% | +$315K | 0.23% | 34 |
|
|
2024
Q4 | $1.41M | Hold |
569,832
| – | – | 0.22% | 32 |
|
|
2024
Q3 | $655K | Hold |
569,832
| – | – | 0.09% | 40 |
|
|
2024
Q2 | $627K | Hold |
569,832
| – | – | 0.07% | 37 |
|
|
2024
Q1 | $707K | Buy |
+569,832
| New | +$707K | 0.08% | 37 |
|